Written by David Roberts, MPH
Nrf2 is a transcription factor that stays inactive until a chemical signal releases it. Once released, it switches on more than 600 protective genes. Sulforaphane activates it by modifying a single cysteine on the protein that holds it.
Key Takeaways
- ✓Your cells carry a built-in defense switch.
- ✓Sulforaphane flips that switch directly, no conversion needed.
- ✓Most broccoli supplements sell a precursor, not the active compound that flips the switch.
- ✓Gut conversion of that precursor ranges 1% to 40%.
- ✓The body's own defense output decreases dramatically with age.
What is the Nrf2 pathway?
The Nrf2 pathway is the cell's master control for its own antioxidant and detoxification machinery. Nrf2 does not neutralize anything itself. It turns on the genes that do.
Nrf2 stands for nuclear factor erythroid 2-related factor 2, a transcription factor: a protein whose job is switching genes on. [4]
Under ordinary conditions, it barely exists. A partner protein called KEAP1 grabs newly made Nrf2 and hands it to a disposal complex, where it is tagged and destroyed within minutes. [1]
That constant destruction is what's important. It keeps the system primed, so the cell can flood itself with defensive proteins the moment a signal arrives rather than waiting to build the machinery from scratch.
The design also explains why the response is fast. Nothing has to be transcribed to start the process, because the protein that starts it is already being made and destroyed continuously.
This is a different model than simply taking an antioxidant (like Vitamin C, for example). An antioxidant molecule neutralizes what it meets and is consumed in the process, roughly one for one.
Activating Nrf2 instead turns on the production line. The cell builds enzymes that work catalytically, handling many molecules each and continuing to work long after the original signal has cleared. [1]
This is also why the pathway is described as the cell's internal defense system rather than an external one. Everything it produces is built by the cell, from the cell's own materials, on demand.
The same architecture appears across species, which is a signal that it is doing something fundamental rather than incidental. Nrf2 and its partner protein are conserved well beyond humans. [4]
How does Nrf2 get switched on?
KEAP1 releases Nrf2 when one of its own cysteine residues is chemically modified. KEAP1 is the sensor, and its cysteines are the sensing surface.
Human KEAP1 carries 27 cysteine residues, each providing a sulfhydryl group that responds to a different class of signal. [2]
They are not interchangeable. Metals and hydrogen peroxide register at one pair of cysteines. Other compounds register at others. Sulforaphane works primarily through a single residue, C151. [1]
Once KEAP1 loses its grip, Nrf2 accumulates instead of being destroyed, moves into the nucleus, pairs with a small Maf protein, and binds a short DNA sequence called the antioxidant response element. [1][4]
That sequence sits in the regulatory region upstream of every gene in the protective set, which is what allows a single binding event to open a whole battery of them at once. [1]
The cysteine specificity matters commercially as well as biologically. A compound that cannot reach and modify the right residue does not activate the pathway, whatever its label says.
The pathway, four steps
1. Held
KEAP1 binds Nrf2 in the cytoplasm and routes it for destruction. Nrf2 levels stay near zero.
↓
2. Signaled
Sulforaphane modifies cysteine C151 on KEAP1. KEAP1 can no longer hand Nrf2 to the disposal complex.
↓
3. Released
Nrf2 accumulates and travels into the nucleus, where it pairs with a small Maf protein.
↓
4. Transcribing
The pair binds the antioxidant response element and switches on the protective gene set.
What do Nrf2 target genes build?
They build an entire toolkit rather than a single antioxidant. High-throughput sequencing has identified more than 600 Nrf2 target genes. [1]
Those genes fall into recognizable groups, and the grouping explains why one switch produces such a broad response.
| What the genes build | Examples |
|---|---|
| Glutathione supply | Glutamate-cysteine ligase, the rate-limiting enzyme for making glutathione, plus glutathione reductase [1][3] |
| Direct antioxidant enzymes | NAD(P)H quinone oxidoreductase 1, heme oxygenase 1, thioredoxin and thioredoxin reductase [1] |
| Conjugating enzymes | Glutathione S-transferases and other Phase II transferases that tag compounds for removal [1][4] |
| Export machinery | Solute carrier and ATP-binding cassette transporters that move tagged compounds out of the cell [1] |
| Cellular cleanup | Autophagy proteins including p62, ULK1 and ATG5, plus proteasome subunits that clear damaged proteins [1] |
| Reducing power | Glucose 6-phosphate dehydrogenase and isocitrate dehydrogenase 1, which regenerate NADPH to run the rest [1] |
Read the table as a supply chain rather than a list. Nrf2 turns on the enzymes that tag a compound, the transporters that carry it out, and the reducing power that keeps both running.
This is the part that separates the Nrf2 pathway from a supplement that supplies a single antioxidant. One switch coordinates the whole sequence, including the cleanup crews that clear damaged proteins and worn-out organelles. [1]
The evidence that the coordination matters comes from removing it. Animals lacking functional Nrf2 show markedly greater sensitivity to a range of chemical and oxidative insults. [4]
Why does Nrf2 activity matter more with age?
Nrf2 transcriptional activity declines with age, and glutathione levels fall along with it. [3]
The gene that limits glutathione production is itself an Nrf2 target, so a quieter switch means a smaller glutathione pool. [3]
Glutathione is not a minor player. It is the cell's most abundant internal antioxidant and the substrate that conjugating enzymes depend on to do their work. [1][3]
That combination is why the pathway becomes more relevant rather than less over time. The demand is still present, but the baseline output declines.
The decline shows up across tissues rather than in one organ. Impaired Nrf2 activity with age has been documented in cartilage, heart muscle, skeletal muscle, kidney, liver and neural tissue. [3]
It compounds with a second age-related shift. Mitochondrial efficiency tends to fall over the same period, which raises the load on exactly the defenses that are producing less. [3]
None of this is a reason for alarm at any particular age. The important question is not whether the pathway works, but how much capacity it still has.
What makes sulforaphane the most-studied Nrf2 activator?
Sulforaphane acts on KEAP1 directly, and researchers have pinned down exactly where.
Mutagenesis work identified C151 as the cysteine sulforaphane targets. Cells engineered to carry a modified C151 showed nuclear translocation of Nrf2 and induction of its target genes impeded by more than 75%. [1]
That result is unusually accurate and proven for a nutritional compound. Change one amino acid and most of the effect disappears, which establishes the route rather than merely correlating with it.
Sulforaphane, when stable, also absorbs well. Upwards of 70% of an administered dose is recovered in urine as thiol conjugates, confirming it reaches cells and interacts with them. [1]
C151 is highly reactive because basic amino acids surround it, which makes it chemically easy to modify. The pathway has a preferred entry point, and sulforaphane fits it. [1]
Size and solubility help too. Sulforaphane is a small molecule that dissolves in fat, so it crosses cell membranes and reaches targets inside the cell rather than working only in the bloodstream.
It also clears quickly, with a biological half-life measured in hours. [1] The effect outlasts the molecule because it leaves behind newly transcribed enzymes.
That combination, a defined molecular target and rapid clearance, is why sulforaphane has been studied more heavily than any other dietary Nrf2 activator.
Why do most Nrf2 activation supplements underdeliver?
Most broccoli supplements do not contain sulforaphane. They contain glucoraphanin, the precursor, and rely on the body to make the conversion. In fact, only two supplements on the market contain sulforaphane.
Converting glucoraphanin into sulforaphane requires the enzyme myrosinase. Plant myrosinase is destroyed by heat during processing, which leaves the job to bacteria in the colon. [2]
Those bacteria vary enormously between people. Measured conversion runs from 1% to 40% of the dose, and no consumer or clinician has a practical way to know which end of that range applies to them. [2]
The variability is large enough to sink a study. A large clinical trial using a myrosinase-inactive broccoli sprout extract could not reach statistical significance. [2]
A second problem is that broccoli contains epithiospecifier protein, which diverts the reaction toward sulforaphane nitrile, an inactive product. Under some conditions, the yield runs as high as 75% nitrile. [2]
The pharmacokinetics demonstrate this gap clearly. Around 10% of a glucoraphanin dose is recovered as sulforaphane conjugates in urine, against upwards of 70% for sulforaphane given directly. [1]
A milligram figure on a glucoraphanin label describes what went into the capsule. It does not describe what reaches the cell.
Some manufacturers respond by adding myrosinase to the capsule alongside the precursor. Stomach acid degrades the enzyme before it reaches the small intestine, which is where absorption happens.
Others point to broccoli sprouts, which do carry far more glucoraphanin than mature broccoli. Sprouts remain a good food, and they still deliver the precursor rather than the active compound.
The practical consequence is that two people can take an identical glucoraphanin capsule and receive very different amounts of sulforaphane, with no way to tell which of them they are. [2]
Several things shift where a given person lands: gut bacterial composition, stomach acidity, recent antibiotic use, and how the product was processed before it reached the shelf. [2]
Assay work makes this measurable rather than theoretical. Testing a broccoli product for its precursor content alone says nothing about the sulforaphane it will yield. [2]
That is the argument for testing finished product for sulforaphane itself, and for reading a label to see which of the two compounds it lists.

What does stabilized sulforaphane change?
It removes the conversion step. Sulforaphane is chemically unstable, which is why most manufacturers use the precursor instead, and stabilizing the active compound is the hard problem in this category.
There is more than one way to solve it. One way is to stabilize sulforaphane using chemical solvents. BrocElite Plus is stabilized without them, which is what makes it the only naturally derived stabilized sulforaphane available.
In Mara Labs' own 2023 laboratory work, BrocElite Plus induced glutathione 120% over baseline in HepG2 liver cells across 24 hours.
That was 34% more than a solvent-stabilized sulforaphane product tested alongside it, and a glucoraphanin product with added myrosinase produced no statistically significant induction above background.
Company data: HepG2 cell line, immunofluorescence measured against vehicle on a plate reader. [5]
The second arm tested people rather than cells. One 10 mg serving of BrocElite Plus induced Nrf-2 in buccal cells swabbed two hours later, at p<0.05.
Twenty milligrams of the solvent-stabilized comparator produced no direct induction. Company data, ex vivo and in vivo buccal immunofluorescence. [5]
Half the dose, and only one of them moved the marker in a living person.

BrocElite® Plus
10 mg stabilized sulforaphane plus 650 mg broccoli seed complex per 2-capsule serving. The active compound delivered directly, with no precursor and no conversion step.
No glucoraphanin, no chemical solvents, no fillers. Made in Charlottesville, Virginia, with every batch third-party tested for sulforaphane content, glyphosate, heavy metals and contaminants. 100-day money-back guarantee on your first bottle.
See BrocElite® PlusFrequently Asked Questions
What is the Nrf2 pathway?
Nrf2 is a transcription factor that controls the cell's antioxidant and detoxification genes. A partner protein called KEAP1 normally holds Nrf2 and routes it for destruction. When a signal modifies KEAP1, Nrf2 is released, enters the nucleus, and switches on more than 600 identified target genes.
How does sulforaphane activate Nrf2?
Sulforaphane chemically modifies a specific cysteine residue on KEAP1 known as C151, which stops KEAP1 from routing Nrf2 for destruction. In cells engineered with a modified C151, Nrf2 nuclear translocation and target gene induction were impeded by more than 75%, which identifies C151 as the route.
What is the difference between sulforaphane and glucoraphanin?
Glucoraphanin is the precursor and sulforaphane is the active compound. Glucoraphanin must be converted by the enzyme myrosinase before cells can use it, and colonic conversion has been measured at anywhere from 1% to 40% of the dose. Around 10% of a glucoraphanin dose is recovered in urine as sulforaphane conjugates, against upwards of 70% when sulforaphane is given directly.
Does Nrf2 activity change with age?
Nrf2 transcriptional activity declines with age. Because the rate-limiting enzyme for glutathione synthesis is itself an Nrf2 target gene, that decline is accompanied by age-related loss of glutathione, the cell's most abundant internal antioxidant.
What should you look for in an Nrf2 activation supplement?
Check whether the label lists sulforaphane or glucoraphanin, since only one of them is the active compound. Check whether stabilization used chemical solvents. Check whether the manufacturer publishes third-party testing for actual sulforaphane content rather than precursor content alone.
Sources
[1] Dinkova-Kostova, A.T., Fahey, J.W., Kostov, R.V., Kensler, T.W. "KEAP1 and done? Targeting the NRF2 pathway with sulforaphane." Trends in Food Science & Technology, 2017.
https://pmc.ncbi.nlm.nih.gov/articles/PMC5725197/
[2] Houghton, C.A., Fassett, R.G., Coombes, J.S. "Sulforaphane and Other Nutrigenomic Nrf2 Activators: Can the Clinician's Expectation Be Matched by the Reality?" Oxidative Medicine and Cellular Longevity, 2016.
https://doi.org/10.1155/2016/7857186
[3] Houghton, C.A. "Sulforaphane: Its 'Coming of Age' as a Clinically Relevant Nutraceutical in the Prevention and Treatment of Chronic Disease." Oxidative Medicine and Cellular Longevity, 2019.
https://doi.org/10.1155/2019/2716870
[4] Boddupalli, S., Mein, J.R., Lakkanna, S., James, D.R. "Induction of Phase 2 Antioxidant Enzymes by Broccoli Sulforaphane: Perspectives in Maintaining the Antioxidant Activity of Vitamins A, C, and E." Frontiers in Genetics, 2012.
https://doi.org/10.3389/fgene.2012.00007
[5] Gildea, J., Katz, M., Roberts, D. "Sulforaphane Induction of Nrf-2." Mara Labs white paper, 2023. Company data.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before beginning any new supplement, especially if pregnant, nursing, on medication, or managing a condition. Individual results may vary.
0 Comments